Palo Alto Investors LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001306923

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltHigh Turnover how tags are computed

Q4 2025 · 49 positions · Total reported value $718.35M · Top-10 concentration 67.8% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 51.8% · 4 new · 25 cut · 0 exited

Active Share (vs S&P 500): 99.8% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -2.7% · vs SPY -4.8% · Prev Value $723.72M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -3.2% · vs SPY -5.3% · Latest Value $672.15M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q4 2025 13F filing, Palo Alto Investors LP disclosed 49 equity positions with a combined reported value of $718.35M. The filing implies a focused portfolio: its ten largest positions account for 67.8% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q4 2025 were INSM ($85.19M), FOLD ($74.13M), PTCT ($68.66M). By sector, the heaviest allocations are Health Care 88.7%, Financials 1.0%. Versus the prior quarter, allocation shifted toward Other (+1.6pp) and away from Health Care (-1.4pp).

Versus the prior quarter, Palo Alto Investors LP opened 4 new positions, trimmed 25 and fully exited 0, a turnover rate of 51.8% of positions. The portfolio's overlap with the prior quarter was 82% of names.

The largest new positions opened in Q4 2025 were CMPX ($13.60M), ANNX ($11.97M), CAPR ($6.53M).

Of the 2 positions fully exited versus the prior quarter, the largest were ALNY ($14.74M), RNAM ($4.79M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q4 2025)

  • CMPX COMPASS THERAPEUTICS INC · $13.60M
  • ANNX ANNEXON INC · $11.97M
  • CAPR CAPRICOR THERAPEUTICS INC · $6.53M
  • BCAX BICARA THERAPEUTICS INC · $5.03M
  • XENE XENON PHARMACEUTICALS INC · $4.33M
  • INSP INSPIRE MED SYS INC · $809.04K
  • CMPS COMPASS PATHWAYS PLC · $797.75K

Fully Exited (vs previous quarter)

  • ALNY ALNYLAM PHARMACEUTICALS INC · prev qtr: $14.74M
  • RNAM AVIDITY BIOSCIENCES INC · prev qtr: $4.79M

Insider Transactions (Form 4)

Latest Palo Alto Investors LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Palo Alto Investors LP, based in Palo Alto, CA, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q3 2026) lists 56 positions worth $672.15M in total. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).

Firm Snapshot

  • Headquarters: PALO ALTO, CA, United States
  • SEC registration: 801-58166 (status: Approved), registered 2000-12-05
  • Regulatory AUM (Form ADV): $696.00M as of 2026-03-27
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 6 private funds, of which 6 hedge funds
  • Website: pa-investors.com

Portfolio Structure

  • 56 positions · $672.15M reported value (Q3 2026)
  • Top 10 holdings = 59.9% of reported value
  • Largest position: PTCT (PTC THERAPEUTICS INC) at 8.4%
  • Average position size: $12.00M

Sector Tilt

  • Health Care 99.8%
  • Financials 0.2%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q3 2026: 4 new, 10 added, 25 reduced
  • 17 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 88.7%
Financials 1.0%
Other 10.3%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 489.48K $85.19M 11.86%
11.86%
Hold
2 5.21M $74.13M 10.32%
10.32%
Reduce
3 903.92K $68.66M 9.56%
9.56%
Add
4 2.48M $66.35M 9.24%
9.24%
Add
5 746.26K $44.35M 6.17%
6.17%
Reduce
6 690.03K $33.45M 4.66%
4.66%
Add
7 183.57K $32.31M 4.50%
4.50%
Reduce
8 1.47M $28.80M 4.01%
4.01%
Add
9 58.19K $28.35M 3.95%
3.95%
Hold
10 317.46K $25.21M 3.51%
3.51%
Add
11 7.12M $19.43M 2.71%
2.71%
Reduce
12 1.30M $16.80M 2.34%
2.34%
Add
13 794.51K $16.69M 2.32%
2.32%
Add
14 4.47M $13.86M 1.93%
1.93%
Reduce
15 2.53M $13.60M 1.89%
1.89%
New
16 1.32M $12.61M 1.76%
1.76%
Hold
17 156.42K $12.36M 1.72%
1.72%
Add
18 2.38M $11.97M 1.67%
1.67%
New
19 461.29K $10.61M 1.48%
1.48%
Add
20 641.24K $10.59M 1.47%
1.47%
Add
21 478.22K $9.01M 1.25%
1.25%
Add
22 1.53M $7.04M 0.98%
0.98%
Reduce
23 242.56K $6.79M 0.94%
0.94%
Add
24 226.30K $6.53M 0.91%
0.91%
New
25 1.18M $6.51M 0.91%
0.91%
Reduce
26 41.52K $6.48M 0.90%
0.90%
Reduce
27 212.50K $5.78M 0.81%
0.81%
Reduce
28 298.57K $5.03M 0.70%
0.70%
New
29 538.08K $4.82M 0.67%
0.67%
Reduce
30 1.57M $4.72M 0.66%
0.66%
Hold
31 96.52K $4.33M 0.60%
0.60%
New
32 110.72K $4.23M 0.59%
0.59%
Hold
33 33.64K $2.87M 0.40%
0.40%
Hold
34 18.12K $2.57M 0.36%
0.36%
Hold
35 72.02K $2.29M 0.32%
0.32%
Reduce
36 41.23K $2.16M 0.30%
0.30%
Hold
37 19.61K $1.87M 0.26%
0.26%
Hold
38 59.98K $1.82M 0.25%
0.25%
Hold
39 221.07K $1.57M 0.22%
0.22%
Hold
40 1.04M $1.19M 0.17%
0.17%
Hold
41 225.47K $1.17M 0.16%
0.16%
Hold
42 3.98K $1.02M 0.14%
0.14%
Hold
43 8.77K $809.04K 0.11%
0.11%
New
44 115.62K $797.75K 0.11%
0.11%
New
45 24.50K $573.79K 0.08%
0.08%
Hold
46 108.86K $573.72K 0.08%
0.08%
Hold
47 188.81K $381.39K 0.05%
0.05%
Hold
48 15.05K $85.47K 0.01%
0.01%
Hold
49 146.02K $42.20K 0.01%
0.01%
Hold

FAQ

What did Palo Alto Investors LP buy in 2025-Q4?

In its 2025-Q4 13F filing, Palo Alto Investors LP reported 49 equity positions worth $718.35M in aggregate; its largest disclosed positions were INSM ($85.19M), FOLD ($74.13M), PTCT ($68.66M).

How large is Palo Alto Investors LP's portfolio?

Palo Alto Investors LP reported $718.35M of long equity holdings across 49 positions as of 2025-Q4. Top-10 holdings account for 67.8% of reported value.

What is Palo Alto Investors LP's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/palo-alto-investors/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →